Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.
Peptide A
Cosmetic
Copper-binding tripeptide with potent wound-healing, skin-remodeling, and gene-regulatory properties.
Peptide B
Peptide Blends
Wolverine's healing duo plus GHK-Cu — soft-tissue recovery with a cosmetic kicker for skin, hair, and scars.
Typical vial
50 mg
Typical dose
200-500 mcg
Half-life
~30-60 minutes (plasma)
FDA status
Not FDA approved as a drug. Widely used as a cosmetic ingred…
Typical vial
70 mg
Typical dose
250 + 2000 + 1000 (BPC + TB + GHK) mcg
Half-life
BPC-157 ~4 h; TB-500 ~6-8 h; GHK-Cu ~minutes systemically (longer in tissue)
FDA status
No component FDA approved for human use. FDA issued a warnin…
GHK-Cu effects
Glow Blend (BPC-157 + TB-500 + GHK-Cu) effects
GHK-Cu side effects
Glow Blend (BPC-157 + TB-500 + GHK-Cu) side effects
GHK-Cu dosing ranges
Skin rejuvenation (topical)
1-2% concentration · Once or twice daily · Ongoing
Systemic tissue support (SubQ)
200-500 mcg · Once daily · 4-6 weeks
Wound healing support (SubQ)
200-500 mcg · Once daily near wound site · 2-4 weeks
Glow Blend (BPC-157 + TB-500 + GHK-Cu) dosing ranges
Recovery + cosmetic loading
250 mcg BPC + 2 mg TB-500 + 1-2 mg GHK-Cu · BPC daily, TB-500 twice weekly, GHK-Cu daily · 6-8 weeks
Scar remodelling protocol
250 mcg BPC + 2 mg TB-500 + 2 mg GHK-Cu · BPC daily, TB-500 weekly, GHK-Cu daily (site-local) · 8-12 weeks
Maintenance stack
250 mcg BPC + 1 mg TB-500 + 1 mg GHK-Cu · BPC 3-4x weekly, others weekly · Ongoing cycles
GHK-Cu: Copper-binding tripeptide with potent wound-healing, skin-remodeling, and gene-regulatory properties. Typical dose 200-500 mcg. Glow Blend (BPC-157 + TB-500 + GHK-Cu): Wolverine's healing duo plus GHK-Cu — soft-tissue recovery with a cosmetic kicker for skin, hair, and scars. Typical dose 250 + 2000 + 1000 (BPC + TB + GHK) mcg. Both fall under the Cosmetic and Peptide Blends categories.
Stacking GHK-Cu with Glow Blend (BPC-157 + TB-500 + GHK-Cu) is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.
GHK-Cu is typically dosed: Once or twice daily for Skin rejuvenation (topical); Once daily for Systemic tissue support (SubQ); Once daily near wound site for Wound healing support (SubQ). Glow Blend (BPC-157 + TB-500 + GHK-Cu) is typically dosed: BPC daily, TB-500 twice weekly, GHK-Cu daily for Recovery + cosmetic loading; BPC daily, TB-500 weekly, GHK-Cu daily (site-local) for Scar remodelling protocol; BPC 3-4x weekly, others weekly for Maintenance stack.
GHK-Cu: Not FDA approved as a drug. Widely used as a cosmetic ingredient without requiring drug approval for topical formulations. Glow Blend (BPC-157 + TB-500 + GHK-Cu): No component FDA approved for human use. FDA issued a warning letter in 2024 regarding compounded BPC-157 products.
Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.
Get Started Free